THOUSAND OAKS, Calif.–(BUSINESS WIRE)– Fertility & Surgical Associates of California (FSAC) is excited to announce the addition of Dr. Amy Dhesi, a distinguished reproductive endocrinologist and infertility specialist, who will officially join the practice in January 2025. Dr. Dhesi brings over a decade of expertise in reproductive medicine, enriching FSAC’s mission to provide exceptional, compassionate, and innovative fertility care to individuals and families across Southern California.
Dr. Dhesi’s expertise extends beyond clinical practice; she is also a respected researcher with contributions to studies on polycystic ovary syndrome (PCOS), endometriosis, and the impact of metabolic health on fertility. Her research has been presented at top medical conferences and published in prestigious journals, highlighting her commitment to advancing the field of reproductive medicine. Fluent in Spanish, Dr. Dhesi is dedicated to serving a diverse community, supporting patients through their fertility journey with empathy and personalized care.
“We are thrilled to welcome Dr. Dhesi to FSAC,” said Dr. Mousa Shamonki, FSAC’s Co-Medical Director. “Her experience, combined with her patient-centered approach, aligns perfectly with our mission to offer cutting-edge care tailored to the needs of each patient.”
Dr. Dhesi will offer both in-person and telehealth consultations at FSAC’s Thousand Oaks and Encino locations. Patients are already scheduling appointments for her upcoming arrival.
Dr. Dhesi earned her medical degree from the University of California, San Francisco, followed by a residency in Obstetrics and Gynecology at UCLA. She completed a fellowship in Reproductive Endocrinology and Infertility at Rutgers University. Throughout her career, Dr. Dhesi has held prominent positions in various Southern California fertility centers, most notably at Kaiser Permanente, where she served as a Partner Physician and clinical leader. Her extensive experience in tackling complex fertility cases has made her a trusted expert in the field.
“Dr. Dhesi’s depth of experience and her unwavering commitment to patient care make her an invaluable addition to our team,” said Dr. Richard Buyalos, FSAC’s Co-Medical Director. “We are confident her expertise in advanced reproductive technologies will greatly benefit our patients.”
Donna Hoffman, Executive Director of FSAC, echoed this enthusiasm: “Dr. Dhesi’s background and compassionate approach will ensure our patients continue to receive the high-quality, personalized care they deserve.”
In addition to her clinical work, Dr. Dhesi is an active participant in reproductive medicine research. Her research interests focus on expanding fertility options, including the study of PCOS, endometriosis, and the intersection of metabolic health and fertility. She has also contributed to research aimed at improving fertility care for transgender individuals.
“I am thrilled to join FSAC and continue helping patients achieve their dream of parenthood,” said Dr. Dhesi. “Collaborating with such a dedicated team and utilizing the latest advancements in reproductive medicine excites me as we work to make a significant impact on our patients’ lives.”
Dr. Dhesi joins a renowned team at FSAC, including Dr. Gary Hubert, Dr. Richard Buyalos, Dr. Mousa Shamonki, and Dr. Holly Mehr, all of whom share a passion for offering hope and resilience to those facing fertility challenges. Together, they aim to provide the best possible care for their diverse patient base.
Related topics:
